$26.41
-0.560 (-2.08%)
At Close: Jul 31, 2026
Principia Biopharma (PRNB) Receives a Buy from Stifel Nicolaus
06:15am, Wednesday, 08'th Apr 2020
In a report released yesterday, Derek Archila from Stifel Nicolaus maintained a Buy rating on Principia Biopharma (PRNB), with a price target of $76.00.
Principia Biopharma (PRNB) Receives a Buy from Stifel Nicolaus
06:15am, Wednesday, 08'th Apr 2020
In a report released yesterday, Derek Archila from Stifel Nicolaus maintained a Buy rating on Principia Biopharma (PRNB – Research
Momenta Pharma (MNTA) Gets a Buy Rating from Stifel Nicolaus
10:40pm, Tuesday, 07'th Apr 2020
In a report released today, Derek Archila from Stifel Nicolaus reiterated a Buy rating on Momenta Pharma (MNTA). The company's shares closed last Tuesday
Momenta Pharma (MNTA) Gets a Buy Rating from Stifel Nicolaus
10:40pm, Tuesday, 07'th Apr 2020
In a report released today,
Derek Archila
from Stifel Nicolaus reiterated a
Buy
rating on Momenta Pharma (
MNTA
–
Research Report
). The company’s shares closed last Tuesday at $26.49.
According t
Hedge Funds Have Never Been More Bullish On Taubman Centers, Inc. (TCO)
09:01pm, Tuesday, 07'th Apr 2020
Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted
Hedge Funds Have Never Been This Bullish On Hostess Brands, Inc. (TWNK)
09:01pm, Tuesday, 07'th Apr 2020
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
Intra-Cellular Therapies Inc (ITCI): Are Hedge Funds Right About This Stock?
09:01pm, Tuesday, 07'th Apr 2020
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
Should You Avoid Mueller Water Products, Inc. (MWA)?
09:01pm, Tuesday, 07'th Apr 2020
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
Is Pacira Pharmaceuticals Inc (PCRX) Going to Burn These Hedge Funds?
09:00pm, Tuesday, 07'th Apr 2020
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
Pacira Biosciences Inc (NASDAQ:PCRX) Shares Sold by AQR Capital Management LLC
08:24am, Tuesday, 07'th Apr 2020
AQR Capital Management LLC cut its stake in shares of Pacira Biosciences Inc (NASDAQ:PCRX) by 75.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and E
Northland Capital Markets Initiates Coverage On Pacira BioSciences with Outperform Rating, Announces Price Target to $50
12:00am, Tuesday, 07'th Apr 2020Mason Street Advisors LLC Has $658,000 Stock Holdings in Pacira Biosciences Inc (NASDAQ:PCRX)
12:08pm, Monday, 06'th Apr 2020
Mason Street Advisors LLC raised its position in Pacira Biosciences Inc (NASDAQ:PCRX) by 2.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and
How This Top Fund Manager Seeks Stocks That Benefit From The Coronavirus Stock Market
12:00pm, Monday, 06'th Apr 2020
Amid the coronavirus stock market crash, Delaware Funds' Alex Ely seeks stocks that benefit from the crisis.
Analysts Offer Insights on Healthcare Companies: Pfizer (PFE) and Seattle Genetics (SGEN)
02:40am, Monday, 06'th Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Pfizer (PFE) and Seattle Genetics (SGEN) with bullish
Sign In
Buy PCRX